Automated Nucleic Acid Extraction Devices Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $9.96 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%.  The growth in the forecast period can be attributed to increased demand for personalized medicine, increasing demand for automation, increasing focus on precision medicine, increasing demand for point-of-care testing, integration with next-generation sequencing. Major trends in the forecast period include technological advancements, increasing demand for molecular diagnostics, miniaturization of automated systems, point-of-care testing , integration of artificial intelligence (ai) and data analytics.

A growing number of research and development activities is expected to propel the growth of the automated nucleic acid extraction devices market going forward. Research and development activities are activities carried out by businesses to inquire about and gather market information prior to the start of the development process in order to create and introduce new goods and services to the market and increase the bottom line of the business. The automated nucleic acid extraction devices are used in research and development activities for clinical diagnosis, biological analysis, and environmental monitoring to boost companies’ efforts to develop new solutions. For instance, in July 2022, according to the World Health Organization (WHO), a Switzerland-based specialized health agency of the United Nations, due to the increasing investment made by the countries during the COVID-19 pandemic, the percentage of nations equipped to conduct genomic surveillance rose from 54% to 68% between March 2021 and January 2022. Therefore, the growing number of research and development activities is driving the growth of the automated nucleic acid extraction devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp

The automated nucleic acid extraction devices market covered in this report is segmented –

1) By Type: Instruments, Kits, Consumables

2) By Product: Fully Automated, Semi-Automated

3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes

Product innovation is a key trend gaining popularity in the market for automated nucleic acid extraction devices. Major companies operating in the automated nucleic acid extraction devices market are introducing innovative products to sustain their position in the market. For instance, in August 2022, Aurora Biomed, a Canada-based manufacturer of automated medical equipment, introduced the VERSA NAP Automated DNA Extraction Systems (also known as the automated nucleic acid extraction system) to automate DNA and RNA extractions and their related purification protocols. The system can process 1-96 samples at the same time and is capable of isolating pure, high-quality DNA or RNA with its plate grippers and transporters, and gives high nucleic acid results.

The automated nucleic acid extraction devices market report table of contents includes:

 

1. Executive Summary
2. Automated Nucleic Acid Extraction Devices Market Characteristics
3. Automated Nucleic Acid Extraction Devices Market Trends And

Strategies

4. Automated Nucleic Acid Extraction Devices Market – Macro Economic Scenario
5. Global Automated Nucleic Acid Extraction Devices Market Size and Growth

.

.

.

31. Global Automated Nucleic Acid Extraction Devices Market Competitive Benchmarking
32. Global Automated Nucleic Acid Extraction Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Automated Nucleic Acid Extraction Devices Market
34. Automated Nucleic Acid Extraction Devices Market Future Outlook and Potential Analysis
35. Appendix

Top Major Players:

 

• QIAGEN NV
• PerkinElmer Inc
• Die Analytik Jena GmbH
• Thermo Fisher Scientific Inc
• Accubiomed Co. Ltd

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model